Revenue - Immuno-Biological Laboratories Co Ltd (TSE:4570) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 460 JPY -0.43%

Updated:

Immuno-Biological Laboratories Co Ltd
Revenue

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Immuno-Biological Laboratories Co Ltd
Revenue Peer Comparison

2309

2370

4880

2183

7079

Company		Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Immuno-Biological Laboratories Co Ltd TSE:4570	Revenue ¥788.1m	CAGR 3-Years 9%	CAGR 5-Years -1%	CAGR 10-Years 2%
	CMIC Holdings Co Ltd TSE:2309	Revenue ¥93.1B	CAGR 3-Years 7%	CAGR 5-Years 6%	CAGR 10-Years 6%
	Medinet Co Ltd TSE:2370	Revenue ¥724.6m	CAGR 3-Years 5%	CAGR 5-Years -5%	CAGR 10-Years -10%
	CellSource Co Ltd TSE:4880	Revenue ¥4.5B	CAGR 3-Years 34%	CAGR 5-Years 30%	CAGR 10-Years N/A
	Linical Co Ltd TSE:2183	Revenue ¥12.5B	CAGR 3-Years 7%	CAGR 5-Years 3%	CAGR 10-Years 13%
	WDB coco Co Ltd TSE:7079	Revenue ¥4.1B	CAGR 3-Years 21%	CAGR 5-Years 23%	CAGR 10-Years N/A

See Also

Based on the financial report for Dec 31, 2023, Immuno-Biological Laboratories Co Ltd's Revenue amounts to 788.1m JPY.

Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for Immuno-Biological Laboratories Co Ltd have been 9% over the past three years , -1% over the past five years , and 2% over the past ten years .

Join more than 133,800+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.